Table 1.
Age (years) | |
Mean±SD | 47±11 |
Median/range | 47/20–75 |
Sex | |
Female/male | 91%/9% |
RAI-administered activity (MBq [mCi]) | |
Mean±SD | 5106±792 [138±21] |
Range | 3700–5500 [100–150] |
Follow-up period (months) | |
Mean±SD | 61±8 |
Median/range | 60/52–83 |
Histology | |
Papillary | 96% |
Follicular | 4% |
T stage | |
T1 | 22% |
T2 | 12% |
T3 | 62% |
T4 | 3% |
Unknown | 1% |
N stage | |
N0 | 22% |
N1 | 42% |
Nx | 36% |
M stage | |
M0 | 100% |
M1 | 0% |
TNM stage | |
I | 53% |
II | 5% |
III | 35% |
IV | 7% |
Risk group | |
Low | 26% |
Intermediate | 71% |
High | 3% |